Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 3/20 | 0.38 |
| ▸ | PRMT6 | Q96LA8 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TARS1 | P26639 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6810123 | 1.00 | POLB (0.39) | POLBAPEX1CTDSP1L3MBTL1ITGB1 | |
| SCHEMBL6805226 | 0.83 | ACACB (0.43) | L3MBTL1ITGB1ITGA4TDP1ALDH1A1 | |
| SCHEMBL6805230 | 0.83 | ACACB (0.43) | L3MBTL1ITGB1ITGA4TDP1ALDH1A1 | |
| SCHEMBL6804598 | 0.82 | LTB4R2 (0.40) | ITGB1ITGA4SLC6A4 | |
| SCHEMBL6809999 | 0.79 | SYK (0.41) | ITGB1ITGA4SMN1; SMN2 | |
| SCHEMBL6804172 | 0.77 | ABCC9 (0.39) | L3MBTL1ITGB1ITGA4TDP1 | |
| SCHEMBL6804169 | 0.77 | ABCC9 (0.39) | L3MBTL1ITGB1ITGA4TDP1 | |
| SCHEMBL6682568 | 0.76 | AKR1C3 (0.52) | POLBAPEX1CTDSP1L3MBTL1TDP1 | |
| SCHEMBL6539936 | 0.73 | ANPEP (0.51) | L3MBTL1TDP1SLC6A4KMT2A | |
| SCHEMBL6539185 | 0.73 | ALDH1A1 (0.68) | L3MBTL1SLC6A4ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | POLB 972/4885APEX1 1235/4885CTDSP1 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.